← BackManchester Peptides gold M logo

Recovery, Skin, Well-Being & Energy

Browse peptide research references covering cellular energy, skin, well-being and recovery-related laboratory topics, including MOTS-C and IGF-1 LR3, with supplied formats and matching COAs where available.

14 options

Vial set · Wolverine

BPC-157 + TB-500

A catalogue combination of two distinct experimental materials discussed in preclinical tissue-repair research.

£60
Product information

A catalogue combination of two distinct experimental materials discussed in preclinical tissue-repair research. Studies consider cell migration, inflammatory signalling and wound-repair pathways, but the combined ‘Wolverine’ format is not an approved clinical formulation.

Evidence and sources at a glance
Human evidence
Robust, replicated controlled human evidence for BPC-157 is absent, and the marketed blend itself lacks an established clinical evidence base.
Regulatory context
The combined product is not an approved UK medicine and should not be described as a proven injury treatment.
Read the full evidence map
PubMed: BPC-157 translational research reviewRead the BPC-157 + TB-500 research guide →For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Vial · 10 mg

KPV

A three-amino-acid fragment of alpha-MSH investigated for anti-inflammatory signalling.

£30
Product information

A three-amino-acid fragment of alpha-MSH investigated for anti-inflammatory signalling. Laboratory and animal studies explore epithelial barriers, skin and gastrointestinal models; effects in people have not been established.

Evidence and sources at a glance
Human evidence
There is no robust clinical evidence establishing KPV as a treatment for inflammatory, skin or gastrointestinal disease.
Regulatory context
KPV is not an approved UK medicine.
Read the full evidence map
PubMed: KPV preclinical studyRead the KPV research guide →For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Vial · 100 mg

GHK-Cu

A naturally occurring copper-binding tripeptide researched in skin, extracellular-matrix and wound-repair biology.

£40
Product information

A naturally occurring copper-binding tripeptide researched in skin, extracellular-matrix and wound-repair biology. Studies explore collagen, elastin, tissue remodelling and hair-follicle pathways, with evidence varying by formulation and use.

Evidence and sources at a glance
Human evidence
Some topical and cosmetic studies exist, but formulation quality, scale and endpoints vary.
Regulatory context
Cosmetic ingredient use is not evidence that injectable GHK-Cu is an approved treatment.
Read the full evidence map
Related laboratory reports100 mg COA · #220567Reports describe the tested samples; batch identity must be matched separately.
PubMed: topical GHK evidence reviewRead the GHK-Cu research guide →For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Vial · 50 mg

Epitalon

A synthetic tetrapeptide explored in research on cellular ageing, oxidative stress and circadian biology.

£40
Product information

A synthetic tetrapeptide explored in research on cellular ageing, oxidative stress and circadian biology. Evidence is limited and does not establish strong longevity claims or an approved anti-ageing use.

Evidence and sources at a glance
Human evidence
The human literature is limited, often small or difficult to verify against modern trial standards.
Regulatory context
Epitalon is not an approved anti-ageing or longevity medicine in the UK.
Read the full evidence map
Related laboratory reports50 mg COA · #220561Reports describe the tested samples; batch identity must be matched separately.
PubMed: Epithalon cell-culture studyRead the Epitalon research guide →For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Vial · 10 mg

Semax

A synthetic ACTH-derived peptide investigated in neurological, cognitive and stress-response research.

£30
Product information

A synthetic ACTH-derived peptide investigated in neurological, cognitive and stress-response research. Published work is limited, and advertised focus or mood effects should not be treated as established clinical outcomes.

Evidence and sources at a glance
Human evidence
Limited clinical literature exists, but replication, reporting and applicability to healthy populations are constrained.
Regulatory context
Semax is not an authorised UK medicine and should not be presented as an approved cognitive treatment.
Read the full evidence map
PubMed: Semax experimental literatureRead the Semax research guide →For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Vial · 10 mg

Selank

A synthetic tuftsin-derived peptide studied in anxiety, stress, cognition and neuroimmune signalling models.

£30
Product information

A synthetic tuftsin-derived peptide studied in anxiety, stress, cognition and neuroimmune signalling models. The evidence base remains limited and does not establish guaranteed mood or cognitive effects.

Evidence and sources at a glance
Human evidence
Limited clinical reports exist, but the evidence is not broad or independently replicated enough for strong treatment claims.
Regulatory context
Selank is not an authorised UK medicine for anxiety, cognition or any other condition.
Read the full evidence map
PubMed: Selank experimental literatureRead the Selank research guide →For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Vial · 1 mg

IGF-1 LR3

A modified, longer-acting analogue of insulin-like growth factor 1 used to investigate IGF-1 receptor signalling.

£50
Product information

A modified, longer-acting analogue of insulin-like growth factor 1 used to investigate IGF-1 receptor signalling. Laboratory research considers cell growth, protein synthesis and metabolic pathways; it is a research reagent rather than an approved medicine.

Evidence and sources at a glance
Human evidence
There is no established clinical evidence base supporting IGF-1 LR3 as a bodybuilding, recovery or anti-ageing treatment.
Regulatory context
IGF-1 LR3 is a research reagent, not an authorised UK medicine.
Read the full evidence map
PubMed: Long R3 IGF-1 literatureRead the IGF-1 LR3 research guide →For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Vial · 50 mg

MOTS-C

A mitochondria-derived peptide studied as a signal connecting cellular stress, energy use and metabolic adaptation.

£50
Product information

A mitochondria-derived peptide studied as a signal connecting cellular stress, energy use and metabolic adaptation. Research explores mitochondrial function, insulin sensitivity and exercise-response pathways, although most intervention evidence remains preclinical.

Evidence and sources at a glance
Human evidence
Human work includes observational biology and early experimental research, not an established therapeutic evidence base.
Regulatory context
MOTS-C is not an approved medicine for metabolism, exercise performance or ageing.
Read the full evidence map
PubMed: MOTS-c research reviewRead the MOTS-C research guide →For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Pen · 80 mg

KLOW

KLOW is a catalogue name commonly used for a four-component research blend of GHK-Cu, BPC-157, TB-500 and KPV.

£90
Product information

KLOW is a catalogue name commonly used for a four-component research blend of GHK-Cu, BPC-157, TB-500 and KPV. It brings together materials investigated in skin and connective-tissue biology, cell migration and inflammatory signalling. Check the product label and batch documentation for the precise formulation of the supplied pen.

For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Pen · 10 mg

MT2 · Melanotan II

Melanotan II (MT2) is a synthetic analogue of alpha-melanocyte-stimulating hormone (alpha-MSH), a signal involved in skin pigmentation.

£50
Product information

Melanotan II (MT2) is a synthetic analogue of alpha-melanocyte-stimulating hormone (alpha-MSH), a signal involved in skin pigmentation. It activates melanocortin receptors and is studied for its ability to stimulate melanin, the pigment responsible for skin colour and tanning. A small early human study observed increased pigmentation, but this does not establish long-term safety or validate this pen formulation. Reported effects include nausea, flushing and changes in moles or freckles. This entry identifies the labelled 10 mg pen format. For research purposes only; not an approved tanning treatment or a substitute for sun protection.

Melanotan II: early human pigmentation studyFor research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Pen · 100 mg

GHK-Cu

A naturally occurring copper-binding tripeptide researched in skin, extracellular-matrix and wound-repair biology.

£85
Product information

A naturally occurring copper-binding tripeptide researched in skin, extracellular-matrix and wound-repair biology. Studies explore collagen, elastin, tissue remodelling and hair-follicle pathways, with evidence varying by formulation and use.

Evidence and sources at a glance
Human evidence
Some topical and cosmetic studies exist, but formulation quality, scale and endpoints vary.
Regulatory context
Cosmetic ingredient use is not evidence that injectable GHK-Cu is an approved treatment.
Read the full evidence map
Related laboratory reports100 mg COA · #220567Reports describe the tested samples; batch identity must be matched separately.
PubMed: topical GHK evidence reviewRead the GHK-Cu research guide →For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Pen · 10 mg + 10 mg

BPC-157 + TB-500

A catalogue combination of two distinct experimental materials discussed in preclinical tissue-repair research.

£80
Product information

A catalogue combination of two distinct experimental materials discussed in preclinical tissue-repair research. Studies consider cell migration, inflammatory signalling and wound-repair pathways, but the combined ‘Wolverine’ format is not an approved clinical formulation.

Evidence and sources at a glance
Human evidence
Robust, replicated controlled human evidence for BPC-157 is absent, and the marketed blend itself lacks an established clinical evidence base.
Regulatory context
The combined product is not an approved UK medicine and should not be described as a proven injury treatment.
Read the full evidence map
PubMed: BPC-157 translational research reviewRead the BPC-157 + TB-500 research guide →For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Pen · 1,000 mg

NAD+

NAD+ (nicotinamide adenine dinucleotide) is a cellular coenzyme involved in oxidation–reduction reactions and energy metabolism.

£90
Product information

NAD+ (nicotinamide adenine dinucleotide) is a cellular coenzyme involved in oxidation–reduction reactions and energy metabolism. It is not a peptide. The listed strength and presentation identify the catalogue format, not proven bioavailability or an established anti-ageing effect.

Related laboratory reports1,000 mg COA · #220603Reports describe the tested samples; batch identity must be matched separately.
PubChem: Nicotinamide adenine dinucleotideFor research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details

Pen · 40 mg

MOTS-C

A mitochondria-derived peptide studied as a signal connecting cellular stress, energy use and metabolic adaptation.

£75
Product information

A mitochondria-derived peptide studied as a signal connecting cellular stress, energy use and metabolic adaptation. Research explores mitochondrial function, insulin sensitivity and exercise-response pathways, although most intervention evidence remains preclinical.

Evidence and sources at a glance
Human evidence
Human work includes observational biology and early experimental research, not an established therapeutic evidence base.
Regulatory context
MOTS-C is not an approved medicine for metabolism, exercise performance or ageing.
Read the full evidence map
PubMed: MOTS-c research reviewRead the MOTS-C research guide →For research and reference purposes only. Listing a product does not establish suitability for medical use.
View full details
Research references (10)

Recovery, skin, well-being and cellular-energy research

This catalogue area brings together distinct research topics rather than one shared effect. GHK-Cu is studied in skin and extracellular-matrix biology; BPC-157 and TB-500-related materials appear mainly in preclinical repair research; KPV is investigated in inflammatory and epithelial-barrier models; MOTS-C and NAD+ relate to cellular energy pathways; and IGF-1 LR3 is used to investigate growth-factor and metabolic signalling in experimental systems.

Semax, Selank and Epitalon are discussed in neurological, stress-response or cellular-ageing research, but the evidence base varies substantially between compounds. Laboratory findings, animal studies and small human studies should not be presented as equivalent forms of evidence.

Use the linked plain-English guides to understand the proposed research idea, then check any matching certificate for the exact sample, measured result and analytical limitations.

Common research questions

Are all recovery peptides supported by human trials?

No. Evidence ranges from laboratory and animal research to limited human studies, and some catalogue materials have no established clinical use.

What does a peptide COA apply to?

A COA applies to the sample identified on that report. It should not automatically be treated as evidence for every product, supplier or batch.